Item 1A. Risk Factors

2K characters. Original on sec.gov · Markdown

Item 1A. Risk Factors

As of March 31, 2024, there have been no material changes to the risk factors set forth in our annual report on Form 10-K for the year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The Company had no sales of unregistered securities during the three months ended March 31, 2024. The following table identifies all repurchases during the three months ended March 31, 2024, of any of the Company’s securities registered under Section 12 of the Securities Exchange Act of 1934, as amended, by or on behalf of the Company or any affiliated purchaser (in thousands, except per share data):


				Total Number of	Maximum Dollar Value
	Total	Average		Shares Purchased as	of Shares that May Yet
	Number of	Price Paid		Part of Publicly	Be Purchased Under the
Period	Shares Purchased	per Share		Announced Programs	Programs (1)
January 1, 2024, to January 31, 2024	93	$	958.52	93	$	2,482,988
February 1, 2024, to February 29, 2024	96		1,045.55	96		2,382,822
March 1, 2024, to March 31, 2024	73		1,097.57	73	$	2,302,184
Total as of March 31, 2024	262	$	1,029.24	262

(1)	The authorizations under the share repurchase program that currently has capacity is scheduled to expire on May 23, 2026, and November 16, 2026. No other share repurchase programs existed during the three months ended March 31, 2024. See Note 9 “Share Repurchase Program” to the Condensed Consolidated Financial Statements for further information on our share repurchases.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information